Hematology

Advances in High-Risk Myelodysplastic Syndromes: Insights and Application for Managed Care With ASH Annual Meeting Coverage

Perspectives on Sickle Cell Disease: Unique Clinical Needs for a Comprehensive, Coordinated Approach to Disease Management

Managed Care Insights on Optimizing the Use of BCMA-Targeted Treatments in Multiple Myeloma

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

Managed Care Considerations on the Evolving Role of Bispecific Antibodies in Hematologic Malignancies

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmacists

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals